InvestorsObserver
×
News Home

Is Athira Pharma Inc (ATHA) Stock at the Top of the Biotechnology Industry?

Monday, March 25, 2024 12:51 PM | InvestorsObserver Analysts

Mentioned in this article

Is Athira Pharma Inc (ATHA) Stock at the Top of the Biotechnology Industry?

Athira Pharma Inc (ATHA) is near the middle in its industry group according to InvestorsObserver. ATHA gets an overall rating of 54. That means it scores higher than 54 percent of stocks. Athira Pharma Inc gets a 59 rank in the Biotechnology industry. Biotechnology is number 20 out of 148 industries.

Overall Score - 54
ATHA has an Overall Score of 54. Find out what this means to you and get the rest of the rankings on ATHA!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector.
These scores are not only easy to understand, but it is easy to compare stocks to each other. You can find the best stock in an industry, or look for the sector that has the highest average score. The overall score is a combination of technical and fundamental factors that serves as a good starting point when analyzing a stock. Traders and investors with different goals may have different goals and will want to consider other factors than just the headline number before making any investment decisions.

What's Happening With Athira Pharma Inc Stock Today?

Athira Pharma Inc (ATHA) stock has risen 1.76% while the S&P 500 is down -0.19% as of 12:49 PM on Monday, Mar 25. ATHA has gained $0.05 from the previous closing price of $2.55 on volume of 207,395 shares. Over the past year the S&P 500 has gained 31.34% while ATHA has gained 9.70%. ATHA lost -$3.09 per share the over the last 12 months. Click Here to get the full Stock Report for Athira Pharma Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App